Menzel Garry E

Director at Adaptimmune Therapeutics PLC · on record since Jun 1, 2023
President and CEO at TCR2 THERAPEUTICS INC. · on record since Feb 13, 2019
COO & Executive VP, Finance at Regulus Therapeutics Inc. · on record since Dec 13, 2012
Senior Vice President, Finance at DAVITA INC. · on record since Sep 11, 2013
Director at TCR2 THERAPEUTICS INC. · on record since Feb 13, 2019
Director at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
Director at Stoke Therapeutics, Inc. · on record since Jan 27, 2021

Insider trading activity of Menzel Garry E

Transactions on record: 86; since Dec 13, 2012

Open-market buys: 0

Open-market sells: 9; $145.2K

Companies traded: 6; last filing Jun 29, 2026

Figures computed from official regulatory filings — .

Companies where Menzel Garry E has traded

Black Diamond Therapeutics, Inc.9 tx · Jun 29, 2026
Stoke Therapeutics, Inc.6 tx · Jun 4, 2025
Adaptimmune Therapeutics PLC13 tx · $43.4K · Jul 1, 2024
TCR2 THERAPEUTICS INC.56 tx · $418.1K · Jun 1, 2023
DAVITA INC.1 tx · Sep 11, 2013
Regulus Therapeutics Inc.1 tx · Dec 13, 2012

Track record of Menzel Garry E

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Menzel Garry E

Co-insiders of Menzel Garry E

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Black Diamond Therapeutics, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 12, 2025	AwardD (derivative)	30,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Stoke Therapeutics, Inc.Listing on record	Jun 4, 2025	AwardD (derivative)	29,747	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 1, 2024	AwardD (derivative)	1,121,604	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Stoke Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	7,639	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 6, 2024	AwardD (derivative)	30,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 10, 2023	Sell	-47,702	0.91 USD	$43.4K	Unusual size	SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	359,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	2,715,816	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	1,251,966	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	3,568,026	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	736,548	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	57,846	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	2,158,776	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 3, 2023	AwardD (derivative)	981,463	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Stoke Therapeutics, Inc.Listing on record	Jun 15, 2023	AwardD (derivative)	19,441	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-433,037	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	Other	-132,730	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-15,120	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jun 1, 2023	Award	200,646	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	Other	-132,729	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-39,681	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	Other	-138,871	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-305,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-138,031	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Black Diamond Therapeutics, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 12, 2025	AwardD (derivative)	30,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Stoke Therapeutics, Inc.Listing on record	Jun 4, 2025	AwardD (derivative)	29,747	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 1, 2024	AwardD (derivative)	1,121,604	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Stoke Therapeutics, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	7,639	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Black Diamond Therapeutics, Inc.Listing on record	Jun 6, 2024	AwardD (derivative)	30,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 10, 2023	Sell	-47,702	0.91 USD	$43.4K	Unusual size	SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	359,700	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	2,715,816	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	1,251,966	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	3,568,026	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	736,548	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	57,846	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2023	AwardD (derivative)	2,158,776	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 3, 2023	AwardD (derivative)	981,463	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Stoke Therapeutics, Inc.Listing on record	Jun 15, 2023	AwardD (derivative)	19,441	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-433,037	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	Other	-132,730	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-15,120	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Jun 1, 2023	Award	200,646	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	Other	-132,729	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-39,681	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	Other	-138,871	—	n/a (No price was disclosed in the filing)		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-305,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TCR2 THERAPEUTICS INC.Listing unverified	Jun 1, 2023	OtherD (derivative)	-138,031	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC